SHINGRIX
INJ PLS SUS 10X50MCG+10X0,5ML
| SÚKL code | 0222844 |
|---|---|
| Name of the product | SHINGRIX |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | SHINGRIX |
| Supplement | INJ PLS SUS 10X50MCG+10X0,5ML |
| Strenght | |
| Pharmaceutical form | Powder and suspension for suspension for injection |
| Package | 10X50MCG+10X0,5ML |
| Route | Intramuscular use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | VARICELLA ZOSTER VIRUS ANTIGEN (GLYCOPROTEIN (VARICELLAE ZOSTER VIRI ANTIGENUM (GLYCOPROTE) |
| ATC group | J07BK03 |
| ATC group name | ZOSTER, PURIFIKOVANÝ ANTIGEN |
Marketing authorisation information
| Registration Number | EU/1/18/1272/002 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | GlaxoSmithKline Biologicals S.A., Rixensart |
| MA Holder country | BELGIE |
cz